[Abstract] Standard cell culture models have been used to investigate disease pathology and to test new therapies for over fifty years. However, these model systems have often failed to mimic the changes occurring within three-dimensional (3-D) space where pathology occurs in vivo. To truthfully represent this, an emerging paradigm in biology is the importance of modelling disease in a physiologically relevant Despite substantial investment in research, much greater understanding of the host-pathogen interaction is required to improve prevention and treatment. Currently, the pathogen is becoming increasingly resistant to commonly used drugs, with the emergence of extensively drug-resistant Mtb.
Materials and Reagents
2. Prepare alginate suspension. Alginate is a natural product and there is variability on the product depending on the species of alginate and environmental conditions. In all studies our group have conducted so far, all the procedures were done with medium viscosity G dominant alginate with viscosity above 250 mPas.
3. Prepare 3% alginate in HBSS without Ca/Mg, with phenol red under sterile conditions and mix it with the buffers to form alginate mix.
Day-2
1. Prepare the alginate-collagen matrix as in Recipe 2 ( Figure 1 ). ii. Adjust the syringe driver speed according to the diameter of the syringe (e.g., appropriate rate for 5 ml syringe to give 10 ml/h). The adjustment of the speed varies dependent on the syringe brand.
iii. Prepare the Borosilicate glass beaker by placing magnetic stirrer inside.
iv. Open the sterile silicon tubes and the nozzles and connect them to the bioelectrospray needle held in the arm of encapsulator.
v. Run 50 ml HBSS without Ca/Mg through the tubing using a 20 ml syringe slowly into empty Borosilicate glass beaker. This will wash the system and check the connection of the needle in the encapsulator arm.
vi. Dry the arm with sterile tissue.
vii. Aspirate the cell-matrix mixture into a 5 ml syringe slowly. Alginate is very viscous and so this must be performed with patience. Avoid creating bubbles. The air enclosed will be ultimately end inside the microspheres, causing them to float.
viii. Connect the 5 ml syringe to the tube, and inject it slowly until it nears the bioelectrospray needle at the end. ix. Pour 100 mM CaCl2 in HBSS (without Ca/Mg) into one of the beakers until it is half-full.
Put beaker under the arm of encapsulator.
x. Place the syringe in the syringe driver and ensure driving screw abuts end of syringe.
Close the doors of the bioelectrosprayer fully. 6. Centrifuge the de-capsulated cells to pellet them at 320 x g for 5 min and discard the supernatant.
7. Wash the cell pellet by re-suspending in HBSS followed by centrifugation.
8. Further use of collagenase is usually not necessary.
9. The de-capsulated cells can be further cultured as a monolayer or used for downstream analysis.
Data analysis
Once and store at 4 °C for up to 2 weeks
